Evotec (EVO) Competitors

Evotec (NASDAQ:EVO) and Lantheus (NASDAQ:LNTH) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment, community ranking and earnings.

Is EVO or LNTH more profitable?

Lantheus has a net margin of 28.57% compared to Evotec's net margin of 0.00%. Lantheus' return on equity of 44.29% beat Evotec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evotec	N/A	N/A	N/A
Lantheus	28.57%	44.29%	23.52%

Do analysts recommend EVO or LNTH?

Evotec currently has a consensus price target of $5.93, indicating a potential upside of 24.13%. Lantheus has a consensus price target of $130.00, indicating a potential upside of 40.30%. Given Lantheus' stronger consensus rating and higher possible upside, analysts plainly believe Lantheus is more favorable than Evotec.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evotec	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Lantheus	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media favor EVO or LNTH?

In the previous week, Evotec and Evotec both had 5 articles in the media. Lantheus' average media sentiment score of 1.65 beat Evotec's score of 0.65 indicating that Lantheus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evotec	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lantheus	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has more volatility and risk, EVO or LNTH?

Evotec has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, Lantheus has a beta of 0.45, suggesting that its stock price is 55% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of EVO or LNTH?

5.8% of Evotec shares are held by institutional investors. Comparatively, 99.1% of Lantheus shares are held by institutional investors. 1.0% of Evotec shares are held by insiders. Comparatively, 1.5% of Lantheus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community prefer EVO or LNTH?

Lantheus received 332 more outperform votes than Evotec when rated by MarketBeat users. Likewise, 65.76% of users gave Lantheus an outperform vote while only 54.55% of users gave Evotec an outperform vote.

Company	Underperform	Outperform
Evotec	Outperform Votes 6 54.55%	Underperform Votes 5 45.45%
Lantheus	Outperform Votes 338 65.76%	Underperform Votes 176 34.24%

Which has preferable valuation and earnings, EVO or LNTH?

Lantheus has higher revenue and earnings than Evotec.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evotec	$777.05M	2.18	-$90.82M	N/A	N/A
Lantheus	$1.50B	4.30	$326.66M	$6.01	15.42

Summary

Lantheus beats Evotec on 14 of the 15 factors compared between the two stocks.